Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02298998 · ClinicalTrials.gov registry record
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 41
- Enrollment target
NCT02298998 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 41 participants.
The verdict
NCT02298998 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
This is a two-arm, randomized-controlled pilot study with 2 year duration. The "intervention" refers to surveillance based on the European Association of Urology (EAU) guidelines and the "control" refers to surveillance based on the American Urological Association (AUA) guidelines.
Interventions
- OTHER Control
- OTHER Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-03 |
| Est. Completion | 2021-06-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02298998
The ClinicalTrials.gov registry entry for NCT02298998 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02298998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02298998 about?
NCT02298998 is a clinical study titled "Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study". This is a two-arm, randomized-controlled pilot study with 2 year duration. The "intervention" refers to surveillance based on the European Association of Urology (EAU) guidelines and the "control" refers to surveillance based on the American Urological Association (AUA) guidelines.
What is the current status of trial NCT02298998?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2013-03. Estimated completion is 2021-06-07.
What interventions are being tested in trial NCT02298998?
The interventions under investigation include: Control (OTHER), Intervention (OTHER).
Who is sponsoring clinical trial NCT02298998?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.